
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CHCHD10 CRISPR/Cas9 KO Plasmid (m) | sc-430459 | 20 µg | $397.00 | |||
CHCHD10 HDR Plasmid (m) | sc-430459-HDR | 20 µg | $445.00 |
Chchd10 encodes the mitochondrial coiled-coil-helix-coiled-coil-helix domain-containing protein CHCHD10, an intermembrane space factor enriched at mitochondrial cristae and contact sites. CHCHD10 contributes to mitochondrial ultrastructure, respiratory chain function, and protein homeostasis, linking it to pathways controlling oxidative phosphorylation, redox balance, and stress-responsive mitochondrial quality control. In mouse systems, disruption of Chchd10 is used to interrogate mechanisms of mitochondrial dysfunction that influence neuronal and muscle physiology and broader bioenergetic remodeling. Altered CHCHD10 activity has been associated with neurodegeneration-related phenotypes and myopathy-like pathology in experimental models, making it relevant for studies of mitochondrial network integrity and proteostatic stress.
CHCHD10 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Chchd10 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Chchd10 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, CHCHD10 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Chchd10 target site.
When co-transfected with CHCHD10 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Chchd10 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.